Global RNA-Targeted Small Molecules Market Growth (Status and Outlook) 2023-2029

February 2023 | 101 pages | ID: G42030FD4DE5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

RNA-targeting small molecules represent a class of small molecules.

LPI (LP Information)' newest research report, the “RNA-Targeted Small Molecules Industry Forecast” looks at past sales and reviews total world RNA-Targeted Small Molecules sales in 2022, providing a comprehensive analysis by region and market sector of projected RNA-Targeted Small Molecules sales for 2023 through 2029. With RNA-Targeted Small Molecules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA-Targeted Small Molecules industry.

This Insight Report provides a comprehensive analysis of the global RNA-Targeted Small Molecules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA-Targeted Small Molecules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA-Targeted Small Molecules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA-Targeted Small Molecules and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA-Targeted Small Molecules.

The global RNA-Targeted Small Molecules market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

RNA-targeting small molecules represent a class of small molecules, organic compounds with traditional drug properties that can bind to RNA secondary or tertiary structures and alter translation patterns, localization, and degradation.

This report presents a comprehensive overview, market shares, and growth opportunities of RNA-Targeted Small Molecules market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• mRNA Translation Regulation
• RNA Splicing Modification
• Direct RNA Targeting
• Indirect RNA Targeting - Epitranscriptomics

Segmentation by application

• Hospitals
• Laboratories
• Phamacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Accent Therapeutics
• Anima Biotech Inc.
• Arrakis Pharmaceuticals
• Epics Therapeutics
• Expansion Therapeutics
• Gotham Therapeutics
• H3 Biomedicine
• Ribometrix
• Skyhawk Therapeutics
• STORM Therapeutics
• Twentyeight-Seven Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNA-Targeted Small Molecules Market Size 2018-2029
  2.1.2 RNA-Targeted Small Molecules Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 RNA-Targeted Small Molecules Segment by Type
  2.2.1 mRNA Translation Regulation
  2.2.2 RNA Splicing Modification
  2.2.3 Direct RNA Targeting
  2.2.4 Indirect RNA Targeting - Epitranscriptomics
2.3 RNA-Targeted Small Molecules Market Size by Type
  2.3.1 RNA-Targeted Small Molecules Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
2.4 RNA-Targeted Small Molecules Segment by Application
  2.4.1 Hospitals
  2.4.2 Laboratories
  2.4.3 Phamacy
2.5 RNA-Targeted Small Molecules Market Size by Application
  2.5.1 RNA-Targeted Small Molecules Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)

3 RNA-TARGETED SMALL MOLECULES MARKET SIZE BY PLAYER

3.1 RNA-Targeted Small Molecules Market Size Market Share by Players
  3.1.1 Global RNA-Targeted Small Molecules Revenue by Players (2018-2023)
  3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2018-2023)
3.2 Global RNA-Targeted Small Molecules Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNA-TARGETED SMALL MOLECULES BY REGIONS

4.1 RNA-Targeted Small Molecules Market Size by Regions (2018-2023)
4.2 Americas RNA-Targeted Small Molecules Market Size Growth (2018-2023)
4.3 APAC RNA-Targeted Small Molecules Market Size Growth (2018-2023)
4.4 Europe RNA-Targeted Small Molecules Market Size Growth (2018-2023)
4.5 Middle East & Africa RNA-Targeted Small Molecules Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas RNA-Targeted Small Molecules Market Size by Country (2018-2023)
5.2 Americas RNA-Targeted Small Molecules Market Size by Type (2018-2023)
5.3 Americas RNA-Targeted Small Molecules Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNA-Targeted Small Molecules Market Size by Region (2018-2023)
6.2 APAC RNA-Targeted Small Molecules Market Size by Type (2018-2023)
6.3 APAC RNA-Targeted Small Molecules Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNA-Targeted Small Molecules by Country (2018-2023)
7.2 Europe RNA-Targeted Small Molecules Market Size by Type (2018-2023)
7.3 Europe RNA-Targeted Small Molecules Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNA-Targeted Small Molecules by Region (2018-2023)
8.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2018-2023)
8.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNA-TARGETED SMALL MOLECULES MARKET FORECAST

10.1 Global RNA-Targeted Small Molecules Forecast by Regions (2024-2029)
  10.1.1 Global RNA-Targeted Small Molecules Forecast by Regions (2024-2029)
  10.1.2 Americas RNA-Targeted Small Molecules Forecast
  10.1.3 APAC RNA-Targeted Small Molecules Forecast
  10.1.4 Europe RNA-Targeted Small Molecules Forecast
  10.1.5 Middle East & Africa RNA-Targeted Small Molecules Forecast
10.2 Americas RNA-Targeted Small Molecules Forecast by Country (2024-2029)
  10.2.1 United States RNA-Targeted Small Molecules Market Forecast
  10.2.2 Canada RNA-Targeted Small Molecules Market Forecast
  10.2.3 Mexico RNA-Targeted Small Molecules Market Forecast
  10.2.4 Brazil RNA-Targeted Small Molecules Market Forecast
10.3 APAC RNA-Targeted Small Molecules Forecast by Region (2024-2029)
  10.3.1 China RNA-Targeted Small Molecules Market Forecast
  10.3.2 Japan RNA-Targeted Small Molecules Market Forecast
  10.3.3 Korea RNA-Targeted Small Molecules Market Forecast
  10.3.4 Southeast Asia RNA-Targeted Small Molecules Market Forecast
  10.3.5 India RNA-Targeted Small Molecules Market Forecast
  10.3.6 Australia RNA-Targeted Small Molecules Market Forecast
10.4 Europe RNA-Targeted Small Molecules Forecast by Country (2024-2029)
  10.4.1 Germany RNA-Targeted Small Molecules Market Forecast
  10.4.2 France RNA-Targeted Small Molecules Market Forecast
  10.4.3 UK RNA-Targeted Small Molecules Market Forecast
  10.4.4 Italy RNA-Targeted Small Molecules Market Forecast
  10.4.5 Russia RNA-Targeted Small Molecules Market Forecast
10.5 Middle East & Africa RNA-Targeted Small Molecules Forecast by Region (2024-2029)
  10.5.1 Egypt RNA-Targeted Small Molecules Market Forecast
  10.5.2 South Africa RNA-Targeted Small Molecules Market Forecast
  10.5.3 Israel RNA-Targeted Small Molecules Market Forecast
  10.5.4 Turkey RNA-Targeted Small Molecules Market Forecast
  10.5.5 GCC Countries RNA-Targeted Small Molecules Market Forecast
10.6 Global RNA-Targeted Small Molecules Forecast by Type (2024-2029)
10.7 Global RNA-Targeted Small Molecules Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Accent Therapeutics
  11.1.1 Accent Therapeutics Company Information
  11.1.2 Accent Therapeutics RNA-Targeted Small Molecules Product Offered
  11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Accent Therapeutics Main Business Overview
  11.1.5 Accent Therapeutics Latest Developments
11.2 Anima Biotech Inc.
  11.2.1 Anima Biotech Inc. Company Information
  11.2.2 Anima Biotech Inc. RNA-Targeted Small Molecules Product Offered
  11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Anima Biotech Inc. Main Business Overview
  11.2.5 Anima Biotech Inc. Latest Developments
11.3 Arrakis Pharmaceuticals
  11.3.1 Arrakis Pharmaceuticals Company Information
  11.3.2 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product Offered
  11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Arrakis Pharmaceuticals Main Business Overview
  11.3.5 Arrakis Pharmaceuticals Latest Developments
11.4 Epics Therapeutics
  11.4.1 Epics Therapeutics Company Information
  11.4.2 Epics Therapeutics RNA-Targeted Small Molecules Product Offered
  11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Epics Therapeutics Main Business Overview
  11.4.5 Epics Therapeutics Latest Developments
11.5 Expansion Therapeutics
  11.5.1 Expansion Therapeutics Company Information
  11.5.2 Expansion Therapeutics RNA-Targeted Small Molecules Product Offered
  11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Expansion Therapeutics Main Business Overview
  11.5.5 Expansion Therapeutics Latest Developments
11.6 Gotham Therapeutics
  11.6.1 Gotham Therapeutics Company Information
  11.6.2 Gotham Therapeutics RNA-Targeted Small Molecules Product Offered
  11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Gotham Therapeutics Main Business Overview
  11.6.5 Gotham Therapeutics Latest Developments
11.7 H3 Biomedicine
  11.7.1 H3 Biomedicine Company Information
  11.7.2 H3 Biomedicine RNA-Targeted Small Molecules Product Offered
  11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 H3 Biomedicine Main Business Overview
  11.7.5 H3 Biomedicine Latest Developments
11.8 Ribometrix
  11.8.1 Ribometrix Company Information
  11.8.2 Ribometrix RNA-Targeted Small Molecules Product Offered
  11.8.3 Ribometrix RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Ribometrix Main Business Overview
  11.8.5 Ribometrix Latest Developments
11.9 Skyhawk Therapeutics
  11.9.1 Skyhawk Therapeutics Company Information
  11.9.2 Skyhawk Therapeutics RNA-Targeted Small Molecules Product Offered
  11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Skyhawk Therapeutics Main Business Overview
  11.9.5 Skyhawk Therapeutics Latest Developments
11.10 STORM Therapeutics
  11.10.1 STORM Therapeutics Company Information
  11.10.2 STORM Therapeutics RNA-Targeted Small Molecules Product Offered
  11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 STORM Therapeutics Main Business Overview
  11.10.5 STORM Therapeutics Latest Developments
11.11 Twentyeight-Seven Therapeutics
  11.11.1 Twentyeight-Seven Therapeutics Company Information
  11.11.2 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product Offered
  11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Twentyeight-Seven Therapeutics Main Business Overview
  11.11.5 Twentyeight-Seven Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. RNA-Targeted Small Molecules Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of mRNA Translation Regulation
Table 3. Major Players of RNA Splicing Modification
Table 4. Major Players of Direct RNA Targeting
Table 5. Major Players of Indirect RNA Targeting - Epitranscriptomics
Table 6. RNA-Targeted Small Molecules Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global RNA-Targeted Small Molecules Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
Table 9. RNA-Targeted Small Molecules Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global RNA-Targeted Small Molecules Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)
Table 12. Global RNA-Targeted Small Molecules Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global RNA-Targeted Small Molecules Revenue Market Share by Player (2018-2023)
Table 14. RNA-Targeted Small Molecules Key Players Head office and Products Offered
Table 15. RNA-Targeted Small Molecules Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global RNA-Targeted Small Molecules Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global RNA-Targeted Small Molecules Market Size Market Share by Regions (2018-2023)
Table 20. Global RNA-Targeted Small Molecules Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global RNA-Targeted Small Molecules Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas RNA-Targeted Small Molecules Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas RNA-Targeted Small Molecules Market Size Market Share by Country (2018-2023)
Table 24. Americas RNA-Targeted Small Molecules Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
Table 26. Americas RNA-Targeted Small Molecules Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)
Table 28. APAC RNA-Targeted Small Molecules Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC RNA-Targeted Small Molecules Market Size Market Share by Region (2018-2023)
Table 30. APAC RNA-Targeted Small Molecules Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
Table 32. APAC RNA-Targeted Small Molecules Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)
Table 34. Europe RNA-Targeted Small Molecules Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe RNA-Targeted Small Molecules Market Size Market Share by Country (2018-2023)
Table 36. Europe RNA-Targeted Small Molecules Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
Table 38. Europe RNA-Targeted Small Molecules Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa RNA-Targeted Small Molecules Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of RNA-Targeted Small Molecules
Table 47. Key Market Challenges & Risks of RNA-Targeted Small Molecules
Table 48. Key Industry Trends of RNA-Targeted Small Molecules
Table 49. Global RNA-Targeted Small Molecules Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global RNA-Targeted Small Molecules Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global RNA-Targeted Small Molecules Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global RNA-Targeted Small Molecules Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Accent Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 54. Accent Therapeutics RNA-Targeted Small Molecules Product Offered
Table 55. Accent Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Accent Therapeutics Main Business
Table 57. Accent Therapeutics Latest Developments
Table 58. Anima Biotech Inc. Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 59. Anima Biotech Inc. RNA-Targeted Small Molecules Product Offered
Table 60. Anima Biotech Inc. Main Business
Table 61. Anima Biotech Inc. RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Anima Biotech Inc. Latest Developments
Table 63. Arrakis Pharmaceuticals Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 64. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product Offered
Table 65. Arrakis Pharmaceuticals Main Business
Table 66. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Arrakis Pharmaceuticals Latest Developments
Table 68. Epics Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 69. Epics Therapeutics RNA-Targeted Small Molecules Product Offered
Table 70. Epics Therapeutics Main Business
Table 71. Epics Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Epics Therapeutics Latest Developments
Table 73. Expansion Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 74. Expansion Therapeutics RNA-Targeted Small Molecules Product Offered
Table 75. Expansion Therapeutics Main Business
Table 76. Expansion Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Expansion Therapeutics Latest Developments
Table 78. Gotham Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 79. Gotham Therapeutics RNA-Targeted Small Molecules Product Offered
Table 80. Gotham Therapeutics Main Business
Table 81. Gotham Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Gotham Therapeutics Latest Developments
Table 83. H3 Biomedicine Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 84. H3 Biomedicine RNA-Targeted Small Molecules Product Offered
Table 85. H3 Biomedicine Main Business
Table 86. H3 Biomedicine RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. H3 Biomedicine Latest Developments
Table 88. Ribometrix Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 89. Ribometrix RNA-Targeted Small Molecules Product Offered
Table 90. Ribometrix Main Business
Table 91. Ribometrix RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Ribometrix Latest Developments
Table 93. Skyhawk Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 94. Skyhawk Therapeutics RNA-Targeted Small Molecules Product Offered
Table 95. Skyhawk Therapeutics Main Business
Table 96. Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Skyhawk Therapeutics Latest Developments
Table 98. STORM Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 99. STORM Therapeutics RNA-Targeted Small Molecules Product Offered
Table 100. STORM Therapeutics Main Business
Table 101. STORM Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. STORM Therapeutics Latest Developments
Table 103. Twentyeight-Seven Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors
Table 104. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product Offered
Table 105. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Twentyeight-Seven Therapeutics Main Business
Table 107. Twentyeight-Seven Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. RNA-Targeted Small Molecules Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA-Targeted Small Molecules Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. RNA-Targeted Small Molecules Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. RNA-Targeted Small Molecules Sales Market Share by Country/Region (2022)
Figure 8. RNA-Targeted Small Molecules Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global RNA-Targeted Small Molecules Market Size Market Share by Type in 2022
Figure 10. RNA-Targeted Small Molecules in Hospitals
Figure 11. Global RNA-Targeted Small Molecules Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. RNA-Targeted Small Molecules in Laboratories
Figure 13. Global RNA-Targeted Small Molecules Market: Laboratories (2018-2023) & ($ Millions)
Figure 14. RNA-Targeted Small Molecules in Phamacy
Figure 15. Global RNA-Targeted Small Molecules Market: Phamacy (2018-2023) & ($ Millions)
Figure 16. Global RNA-Targeted Small Molecules Market Size Market Share by Application in 2022
Figure 17. Global RNA-Targeted Small Molecules Revenue Market Share by Player in 2022
Figure 18. Global RNA-Targeted Small Molecules Market Size Market Share by Regions (2018-2023)
Figure 19. Americas RNA-Targeted Small Molecules Market Size 2018-2023 ($ Millions)
Figure 20. APAC RNA-Targeted Small Molecules Market Size 2018-2023 ($ Millions)
Figure 21. Europe RNA-Targeted Small Molecules Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa RNA-Targeted Small Molecules Market Size 2018-2023 ($ Millions)
Figure 23. Americas RNA-Targeted Small Molecules Value Market Share by Country in 2022
Figure 24. United States RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC RNA-Targeted Small Molecules Market Size Market Share by Region in 2022
Figure 29. APAC RNA-Targeted Small Molecules Market Size Market Share by Type in 2022
Figure 30. APAC RNA-Targeted Small Molecules Market Size Market Share by Application in 2022
Figure 31. China RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 35. India RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe RNA-Targeted Small Molecules Market Size Market Share by Country in 2022
Figure 38. Europe RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
Figure 39. Europe RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)
Figure 40. Germany RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 41. France RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Application (2018-2023)
Figure 48. Egypt RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country RNA-Targeted Small Molecules Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 54. APAC RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 55. Europe RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 57. United States RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 58. Canada RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 59. Mexico RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 60. Brazil RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 61. China RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 62. Japan RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 63. Korea RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 65. India RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 66. Australia RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 67. Germany RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 68. France RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 69. UK RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 70. Italy RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 71. Russia RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 72. Spain RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 73. Egypt RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 74. South Africa RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 75. Israel RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 76. Turkey RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries RNA-Targeted Small Molecules Market Size 2024-2029 ($ Millions)
Figure 78. Global RNA-Targeted Small Molecules Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global RNA-Targeted Small Molecules Market Size Market Share Forecast by Application (2024-2029)